By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immatics Biotechnologies GmbH 

Paul-Ehrlich-Strasse 15

Tuebingen    D-72076  Germany
Phone: 49-7071-565125-0 Fax: 49-7071-565125-99


Company News
Immatics Appoints Katina Dorton As Chief Financial Officer 1/8/2016 9:53:36 AM
Immatics US Launches as Spinout of Immatics and MD Anderson Cancer Center 8/26/2015 6:02:34 AM
MorphoSys AG And immatics biotechnologies GmbH Enter Strategic Alliance In Immuno-oncology 8/25/2015 8:28:04 AM
EU-Funded Consortium Led By immatics biotechnologies GmbH And BioNTech To Advance A Novel Class Of Fully Personalized Therapeutic Cancer Vaccines Into Clinical Trials For Brain Cancer 10/14/2014 10:58:43 AM
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014 6:22:49 AM
Promising Results In Phase 1 Trial Lead immatics biotechnologies GmbH To Continue Work On Vaccine (IMA950) For Glioblastoma 4/23/2014 12:53:51 PM
immatics biotechnologies GmbH, Roche (RHHBY) Ink Cancer Pact Worth Up To $1 Billion 11/13/2013 6:27:11 AM
immatics biotechnologies GmbH Snags $46 Million in Series D Financing Round 10/15/2013 7:58:29 AM
immatics biotechnologies GmbH to Present at CIMT Annual Meeting 2013 in Mainz, Germany 5/13/2013 10:16:12 AM
immatics biotechnologies GmbH' CSO to Present in Major Symposium at 2013 American Association for Cancer Research Annual Meeting in Washington D.C. 4/4/2013 9:55:34 AM